NCT00479076View on ClinicalTrials.gov

A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

22

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions

Neoplasms

Interventions

DRUG

aflibercept (AVE0005)

intravenous infusion

DRUG

S-1

oral administration

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

Sanofi

INDUSTRY

NCT00479076 - A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer Patients | Biotech Hunter | Biotech Hunter